Actively Recruiting
Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study
Led by Istituto Ortopedico Rizzoli · Updated on 2026-05-12
60
Participants Needed
1
Research Sites
272 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To date, arterial embolization constitutes one of the most popular methods in minimally invasive treatment of bone metastases, allowing good results in terms of pain reduction, local control of disease and reduction of peri-operative bleeding, with low invasiveness.
CONDITIONS
Official Title
Arterial Embolization for the Treatment of Bone Metastases: Prospective Observational Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients of either sex aged 18 years or older who are candidates for embolization therapy
- Life expectancy greater than 3 months
- Single metastatic or oligometastatic disease
- Patients with multiple metastases if a particular site causes pain or risk of pathologic fracture
You will not qualify if you...
- Life expectancy less than 3 months or severe functional status impairment (ASA 4)
- Hypovascular metastasis confirmed by angiography or MRI perfusion study with MDC
- Coagulation disorders or low platelet counts
- Active infections
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Istituto Ortopedico Rizzoli
Bologna, Emilia-Romagna, Italy, 40136
Actively Recruiting
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here